Beijing Leadman Biochemistry Co.,Ltd. (300289)’in fiyatı nedir?

Beijing Leadman Biochemistry Co.,Ltd. (300289)’in fiyatı $0.87093245’dir

Beijing Leadman Biochemistry Co.,Ltd. (300289)’in piyasa değeri nedir?

Beijing Leadman Biochemistry Co.,Ltd. (300289)’in piyasa değeri $473.80M’dir.

Beijing Leadman Biochemistry Co.,Ltd. (300289) Temettüler

Beijing Leadman Biochemistry Co.,Ltd. is a prominent entity within the People's Republic of China, specializing in the entire lifecycle – from research and development to manufacturing and distribution – of advanced in vitro diagnostic (IVD) solutions. Its product portfolio encompasses a comprehensive range of biochemical raw materials. This includes critical components like enzymes, coenzymes, antibodies, various buffers, enzyme substrates, culture media, staining reagents, and amino acids. These essential ingredients serve a diverse array of sectors, notably biotechnology, clinical diagnostics, pharmaceutical development, and chemical manufacturing. Beyond raw materials, Leadman also provides specialized biochemistry diagnostic and complementary reagents. Furthermore, the company supplies a sophisticated selection of medical instrumentation. This lineup features the EnigmaML, an automated molecular testing platform designed for both clinical laboratories and various point-of-care settings like clinics and pharmacies. Another key offering is the DiaSys InnovaStar, a compact automated POCT analyzer that delivers laboratory-grade diagnostic accuracy. Customers also benefit from the DiaSys Respons, a versatile random access benchtop analyzer; the CI1000 automatic chemiluminescence immunoassay analyzers; and the IDS-isys, an instrument engineered to boost operational performance and efficiency. Established in 1997, Beijing Leadman Biochemistry maintains its corporate headquarters in Beijing, China.

Yıl	Temettü (hisse bölünmesiyle ayarlanmış)	Değiştir
Sağlanan tarihler için yeterli veri yok.

Yıl

Temettü (hisse bölünmesiyle ayarlanmış)

Değiştir

Sağlanan tarihler için yeterli veri yok.

Yıl	Temettü	Değiştir
Sağlanan tarihler için yeterli veri yok.

Yıl

Temettü

Değiştir

Sağlanan tarihler için yeterli veri yok.

Şirket	Temettü ödemesi sayısı	Ülke
Abbott Laboratories ABT.US	173.00%	US
Stryker Corporation SYK.US	85.00%	US
Medtronic plc MDT.US	178.00%	IE
Boston Scientific Corporation BSX.US	0.00%	US
Edwards Lifesciences Corporation EW.US	0.00%	US

Şirket

Temettü ödemesi sayısı

Ülke